Bionalytical validation study for the determination of unbound ambrisentan in human plasma using rapid equilibrium dialysis followed by ultra performance liquid chromatography coupled to mass spectrometry.
- DOI
- 10.1016/j.jpba.2017.12.030
- Published
- 2018 Feb 20
- Container
- Journal of pharmaceutical and biomedical analysis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jpba.2017.12.030,
title = {Bionalytical validation study for the determination of unbound ambrisentan in human plasma using rapid equilibrium dialysis followed by ultra performance liquid chromatography coupled to mass spectrometry.},
author = {Garcia-Martínez S and Rico E and Casal E and Grisaleña A and Alcaraz E and King N and Leal N and Navarro I and Campanero MÁ},
year = {2018},
journal = {Journal of pharmaceutical and biomedical analysis},
doi = {10.1016/j.jpba.2017.12.030},
url = {https://doi.org/10.1016/j.jpba.2017.12.030}
}RIS
TY - JOUR TI - Bionalytical validation study for the determination of unbound ambrisentan in human plasma using rapid equilibrium dialysis followed by ultra performance liquid chromatography coupled to mass spectrometry. AU - Garcia-Martínez S AU - Rico E AU - Casal E AU - Grisaleña A AU - Alcaraz E AU - King N AU - Leal N AU - Navarro I AU - Campanero MÁ PY - 2018 JO - Journal of pharmaceutical and biomedical analysis DO - 10.1016/j.jpba.2017.12.030 UR - https://doi.org/10.1016/j.jpba.2017.12.030 ER -
APA
S, G., E, R., E, C., A, G., E, A., N, K., N, L., I, N., & MÁ, C. (2018). Bionalytical validation study for the determination of unbound ambrisentan in human plasma using rapid equilibrium dialysis followed by ultra performance liquid chromatography coupled to mass spectrometry.. Journal of pharmaceutical and biomedical analysis. https://doi.org/10.1016/j.jpba.2017.12.030
Source records
- pubmed · retrieved 2026-09-27T12:43:05.044Z